reconstituted refrigerated for up to 28 days
This could lead to the worsening of chronic illnesses and infections and can cause life-threatening complications
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Our targeted IV formulations are designed to optimise the internal environment, complementing the regenerative and performance goals of your peptide programme.
doi: 10.3389/fimmu.2023.1181156 58 HuZChenLZhaoJZhangWJinZSunYet al
Yet despite this, womens health innovation continues to attract only a fraction of the investment directed towards other areas of healthcare